Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-02T15:30:12.059Z Has data issue: false hasContentIssue false

The impact of cocaine on diagnosis stability in psychosis, based on a case report

Published online by Cambridge University Press:  19 July 2023

M. Pérez Machado*
Affiliation:
psychiatry, Institute of Neuropsychiatry and addictions psychiatry, Hospital del Mar, Parc de Salut Mar
L. Cano Roch
Affiliation:
psychiatry, Institute of Neuropsychiatry and addictions psychiatry, Hospital del Mar, Parc de Salut Mar
E. Mur Mila
Affiliation:
psychiatry, Institute of Neuropsychiatry and addictions psychiatry, Hospital del Mar, Parc de Salut Mar psychiatry, Mental Health Research Group, Hospital Del Mar(IMIM), BARCELONA, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Substance-induced psychosis (SIP) is the name given to a psychosis that starts in the context of substance abuse, but persists for days and weeks with no substance use. There is growing recognition that individuals with substance-induced psychosis are more likely to develop a schizophrenia spectrum disorder. Early onset of substance-induced psychosis and cannabis use are predictors of conversion. Nevertheless, more evidence is needed to identify other factors.

Objectives

The objective of this study was to analyze the progression of substance-induced psychosis to several mental disorders, by reporting a case of a cocaine user, and identifying the factors that promote the progression.

Methods

We report the case of a 55 years old male, with long-term consumption of endovenous cocaine and heroin, who has experienced various episodes of substance-induced psychosis in the past.

In 2017, he presented haptic and visual hallucinations oriented as parasite delusion during rehab hospitalization. The symptoms disappear after a few days of risperidone treatment and absence of consumption. Consuming cocaine and heroin ev in previous days.In October 2018 and July 2021 the patient was hospitalized in Dual Pathology for similar episodes oriented as substance-induced psychosis.

In the current episode, the patient was hospitalized in the Dual Pathology Unit due to a psychotic episode described as parasite infestation delusion and prejudice delusion against his family. The last consumption of heroin and cocaine was 3 months ago.

Results

DATE OF HOSPITALIZATIONLAST CONSUME BEFORE HOSPITALIZATIONHABITUAL COMPSUPTION BEFORE HOSPITALIZATIONINICIAL SYMTOMS DURINGHOSPITALIZATIONTREATMENT DURING HOSPITALIZATION
04/12/17 -19/12/17 -1 DAYCOCAINE AND HEROIN: 1/8g/24h ev-PARASITE DELUSION-Haptic HallucinationsRisperidone 2mg/day
25/09/1808/10/181 DAY-COCAINE AND HEROINE: O,5g, 2-3 times a week,ev-PARASITE DELUSION- Haptic and Visual HallucinationsRisperidona hasta 4mg/day
15/06/21 -28/06/21?-COCAINE AND HEROINE: O,5g, 2-3 times a week,ev-PARASITE DELUSION- Behavioral impactRisperidone 3mg/day
15/09/2022-17/10/20223 MONTHS-- PARASITE DELUSION-Behavioural impact- Prejudice delusionPaliperidone 3mg/day

Conclusions

This case report exemplifies the temporal relationship between substance use and the development of psychotic illness. Suggesting substance-induced psychosis as an indicator for the future development of a severe mental disorder. For this reason, more evidence is needed to identify other factors that promote the progression to severe mental disorders and stablish a higher risk group

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.